OFI Invest Asset Management grew its stake in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 6.0% in the second quarter, according to its most recent filing with the SEC. The fund owned 388,480 shares of the company’s stock after acquiring an additional 22,040 shares during the period. OFI Invest Asset Management’s holdings in Procter & Gamble were worth $61,893,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently modified their holdings of PG. Nova Wealth Management Inc. purchased a new stake in shares of Procter & Gamble in the first quarter valued at $26,000. Signature Resources Capital Management LLC lifted its holdings in shares of Procter & Gamble by 67.9% in the second quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock valued at $28,000 after purchasing an additional 72 shares in the last quarter. Quarry LP purchased a new stake in shares of Procter & Gamble in the first quarter valued at $33,000. Mizuho Securities Co. Ltd. lifted its holdings in shares of Procter & Gamble by 566.7% in the first quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company’s stock valued at $34,000 after purchasing an additional 170 shares in the last quarter. Finally, RMG Wealth Management LLC purchased a new stake in shares of Procter & Gamble in the second quarter valued at $37,000. Institutional investors and hedge funds own 65.77% of the company’s stock.
Procter & Gamble Trading Down 0.6%
Procter & Gamble stock opened at $149.69 on Friday. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49. The company has a market capitalization of $350.34 billion, a price-to-earnings ratio of 22.99, a PEG ratio of 3.97 and a beta of 0.36. Procter & Gamble Company has a one year low of $149.45 and a one year high of $180.43. The company’s fifty day moving average price is $155.24 and its two-hundred day moving average price is $159.48.
Insider Buying and Selling
In other news, insider Balaji Purushothaman sold 490 shares of the firm’s stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $74,592.70. Following the sale, the insider directly owned 12,616 shares of the company’s stock, valued at approximately $1,920,533.68. This trade represents a 3.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, COO Shailesh Jejurikar sold 3,986 shares of the firm’s stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $606,788.78. Following the completion of the sale, the chief operating officer directly owned 46,899 shares in the company, valued at approximately $7,139,434.77. This represents a 7.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 149,763 shares of company stock valued at $23,421,279 in the last quarter. Insiders own 0.20% of the company’s stock.
Wall Street Analyst Weigh In
Several analysts recently issued reports on PG shares. BNP Paribas reiterated an “outperform” rating and set a $177.00 price objective on shares of Procter & Gamble in a report on Friday, August 15th. Bank of America cut their price objective on Procter & Gamble from $180.00 to $174.00 and set a “buy” rating for the company in a report on Wednesday. Evercore ISI reiterated an “in-line” rating and set a $170.00 price objective (down from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. Barclays cut their price objective on Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating for the company in a report on Wednesday, October 1st. Finally, Wells Fargo & Company cut their price objective on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating for the company in a report on Thursday, September 25th. Eleven equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat, Procter & Gamble currently has an average rating of “Moderate Buy” and an average target price of $172.21.
Check Out Our Latest Stock Analysis on Procter & Gamble
Procter & Gamble Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- What is the NASDAQ Stock Exchange?
- Bassett Furniture: Buy Now, Sit Back, and Collect Dividends
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- AST SpaceMobile’s Big Win: Shares Soar on New Deal With Verizon
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Catch the Next Bitcoin Rally With These 3 ETFs
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.